- Title
- What do we do now?: Responding to claims of germline gene editing in humans
- Creators
- Megan Allyse - Biomedical Ethics Research Program and Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA. Allyse.megan@mayo.eduYvonne Bombard - Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto, Toronto, ON, CanadaRosario Isasi - J.T Macdonald Foundation Department of Human Genetics and Institute for Bioethics & Health Policy, University of Miami Miller School of Medicine, Miami, FL, USAMarsha Michie - Department of Bioethics, Case Western Reserve University School of Medicine, Cleveland, OH, USAKiran Musunuru - Departments of Medicine and Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USAKelly E Ormond - Department of Genetics and Stanford Center for Biomedical Ethics, Stanford School of Medicine, Stanford, CA, USA
- Publication Details
- Genetics in medicine, Vol.21(10), pp.2181-2183
- Grant note
- K01 HG009542 / NHGRI NIH HHS CIHR
- Academic Unit
- Miller School of Medicine; John P. Hussman Institute for Human Genomics; UMMG Dept of Human Genetics (Dr. John T. Macdonald Foundation)
- Language
- English
- Resource Type
- Journal article
- PMID
- 30914827
- Record Identifier
- 991031613112202976
Journal article
What do we do now?: Responding to claims of germline gene editing in humans
Genetics in medicine, Vol.21(10), pp.2181-2183
2019-10
PMID: 30914827
Metrics
5 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.54 Molecular & Cell Biology - Genetics
- 1.54.1401 Genome Editing
- Web Of Science research areas
- Genetics & Heredity
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites